Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person13
CapsoVision, Inc
Company
Captivision Inc.
Company
MICROVISION, INC.
Company
OZ VISION INC.
Company
PARKERVISION INC
Company
Catheter Precision, Inc.
Company
Covista Inc.
Company
CAE INC
Company
INTRUSION INC
Company
Cycurion, Inc.
Company
CapForce Inc.
Company
CALIX, INC
Company
CADIZ INC
Company
Primary record8
CapsoVision, Inc filed SCHEDULE 13G/A
, as amended (the "Exchange Act") based on an aggregate total of 53,195,592 shares of the Issuer's common stock outstanding as of September 18, 2026, as reported by the Issuer in the prospectus supplement filed pursuant
CapsoVision, Inc filed 8-K
Item 8.01. Other Events. On September 28, 2026, the Company announced that AI Highlights , its AI-assisted reading feature for the CapsoCam Plus system, received clearance from the U.S. Food and Drug Administration on Se
CapsoVision, Inc filed 4
SEC form 4 filed by CapsoVision, Inc (CIK 1378325) on 2026-09-23.
CapsoVision, Inc filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. On September 17, 2026, CapsoVision, Inc. (the Company ) entered into a securities purchase agreement (the Purchase Agreement ) with certain investors (the Purchasers
CapsoVision, Inc filed 4
SEC form 4 filed by CapsoVision, Inc (CIK 1378325) on 2026-09-18.
Outlook Therapeutics, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Chief Financial Officer Transition On August 23, 2026, Outlook
CapsoVision, Inc filed 8-K
Item 8.01. Other Events. As previously announced, on August 13, 2026, CapsoVision, Inc. (the Company ) entered into a Controlled Equity Offering SM Sales Agreement (the Sales Agreement ) with Cantor Fitzgerald & Co. with
CapsoVision, Inc filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. On August 13, 2026, CapsoVision, Inc. (the Company ) entered into a Controlled Equity Offering SM Sales Agreement (the Sales Agreement ) with Cantor Fitzgerald & Co.